Combination of Three Therapies May Slow Progression of Advanced Melanoma


Three therapies—dabrafenib, trametinib, and pembrolizaumab—used in combination may slow advanced melanoma, according to a new study led by researchers at UCLA. Watch the healthminute.tv video below for more information.

#Melanoma #dabrafenib #trametinib #andpembrolizaumabcan #UniversityofCaliforniaLosAngeles

10 views0 comments